510(k) K050596

Device
QUANTIA A1-AT
Applicant
BIOKIT S.A.
510(k) number
K050596
Product code
DEM  
Decision
Substantially Equivalent (SESE)
Decision date
2005-05-13
Date received
2005-03-08
Regulation
866.5130
Classification name
Alpha-1-antitrypsin, Antigen, Antiserum, Control
Medical specialty
Immunology
Review panel
Immunology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
JOAN GUIXER
Address
Llissa D'Amunt Barcelona ES 08186 08186

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code DEM  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K123256HUMAN ALPHA-1 ANTITRYPSIN KIT SPAPLUSThe Binding Site Group , Ltd.2013-07-03
K063610DIMENSION VISTA A1AT FLEX REAGENT CARTRIDGE AND PROTEIN 1 CALIBRATOR AND CONTROL MEDIUM AND HIGHDade Behring, Inc.2007-01-11
K053072N ANTISERA TO HUMAN ALPHA1-ANTITRYPSINDade Behring, Inc.2006-03-28
K052819VITROS CHEMISTRY PRODUCTS AAT REAGENT, CALIBRATOR KIT 99 AND AAT PERFORMANCE VERIFIERS I, II AND IIIOrtho-Clinical Diagnostics, Inc.2005-12-23
K031857ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAYBayer Diagnostics Corp.2003-09-04
K011663MININEPH A-1 ANTITRYPSIN ANTISERUM, HIGH AND LOW SERUM CONTROLSThe Binding Site, Ltd.2001-07-30
K010978TINA-QUANT ALPHA-1 ANTITRYPSINRochdiag2001-05-18
K993444K-ASSAY ALPHA-1 ATKamiya Biomedical Co.1999-11-24
K972640TINA-QUANT ALPHA PARTICLE-1-ANTITRYPSIN ASSAYBoehringer Mannheim Corp.1998-01-09
K973392CHEMMATE LAMBDAVentana Medical Systems, Inc.1997-10-03
K973391CHEMMATE KAPPAVentana Medical Systems, Inc.1997-10-03
K973390CHEMMATE L26 (CD20)Ventana Medical Systems, Inc.1997-10-03
K973389CHEMMATE UCHL1 (CD45RO) PREDILUTED ANTIBODY FOR IMMUNOHISTOCHEMICAL STAININGVentana Medical Systems, Inc.1997-10-03
K965100N-ASSAY TIA ALPHA-1-ANTITRYPSIN TEST KITCrestat Diagnostics, Inc.1997-07-14
K964766IMMAGE IMMUNOCHEMISTRY SYSTEM ALPHA-1-ANTITRYPSIN (AAT)Beckman Instruments, Inc.1997-04-25

Legacy Summary#

summary

FDA Review#

Decision Summary